UNSPSC 51293612: Binedaline hydrochloride

This classification denotes an antidepressant agent with the molecular formula C19H23N3.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier WEK9FVT37G, chemically known as n,n,n-trimethyl-n-(3-phenyl-1h-indol-1-yl)ethylenediamine monohydrochloride but more generally known as binedaline hydrochloride, which bears US NIH Compound Identifier 42509. European Medicines Agency schedules Binedaline hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB25841.

Most nations, for tariff and trade purposes, schedule binedaline hydrochloride under HS 29339990. As of Q4 2014, BINEDALINE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. SMILES: CN(C)CCN(C)N1CC(C2C1CCCC2)C3CCCCC3.CL.

UNSPSC 51293612 Binedaline hydrochloride is a Commodity code with a significant mismatch between its nominal scope and the state and local procurement activity actually tagged under it. The recent opportunity data shows no purchasing activity related to binedaline hydrochloride itself. Instead, Seminole County, Florida posted a solicitation for naloxone and drug deactivation systems—pharmaceuticals and medical devices unrelated to the binedaline code's intended scope. The source provides no evidence of state and local governments buying binedaline hydrochloride through this code or any other recent opportunities tagged to it.

Seminole County, Florida issued IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The IFB closed on July 26, 2023, with a two-year initial term and one-year renewal option; vendors were required to submit unit costs, drug-free workplace certification, and E-Verify compliance documentation, with all shipping and delivery costs included in proposals. The solicitation structure—fixed-fee bidding through the county's e-Procurement Portal with potential FEMA funding—indicates a community health initiative focused on opioid response and emergency preparedness. Beyond this single naloxone procurement, the code shows no recent state and local activity and does not support characterization of issuing-body mix, geographic spread, or market concentration in binedaline hydrochloride purchasing.